This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4u6k
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='4u6k' size='340' side='right'caption='[[4u6k]], [[Resolution|resolution]] 1.50Å' scene=''> | <StructureSection load='4u6k' size='340' side='right'caption='[[4u6k]], [[Resolution|resolution]] 1.50Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4u6k]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4U6K OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[4u6k]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4U6K OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4U6K FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NCO:COBALT+HEXAMMINE(III)'>NCO</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NCO:COBALT+HEXAMMINE(III)'>NCO</scene></td></tr> |
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=NCU:[(1R,5R,7R,8S)-7-(4-AMINO-5-METHYL-2-OXOPYRIMIDIN-1(2H)-YL)-8-HYDROXY-3-METHYL-2,6-DIOXA-3-AZABICYCLO[3.2.1]OCT-5-YL]METHYL+DIHYDROGEN+PHOSPHATE'>NCU</scene>, <scene name='pdbligand=NTT:[(1R,5R,7R,8S)-8-HYDROXY-3-METHYL-7-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2,6-DIOXA-3-AZABICYCLO[3.2.1]OCT-5-YL]METHYL+DIHYDROGEN+PHOSPHATE'>NTT</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=NCU:[(1R,5R,7R,8S)-7-(4-AMINO-5-METHYL-2-OXOPYRIMIDIN-1(2H)-YL)-8-HYDROXY-3-METHYL-2,6-DIOXA-3-AZABICYCLO[3.2.1]OCT-5-YL]METHYL+DIHYDROGEN+PHOSPHATE'>NCU</scene>, <scene name='pdbligand=NTT:[(1R,5R,7R,8S)-8-HYDROXY-3-METHYL-7-(5-METHYL-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-2,6-DIOXA-3-AZABICYCLO[3.2.1]OCT-5-YL]METHYL+DIHYDROGEN+PHOSPHATE'>NTT</scene></td></tr> | ||
| - | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4u6l|4u6l]], [[4u6m|4u6m]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[4u6l|4u6l]], [[4u6m|4u6m]]</div></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4u6k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4u6k OCA], [https://pdbe.org/4u6k PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4u6k RCSB], [https://www.ebi.ac.uk/pdbsum/4u6k PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4u6k ProSAT]</span></td></tr> |
</table> | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | It has been confirmed by our previous studies that a 2',4'-BNA(NC)[N-Me]-modified antisense gapmer displays high affinity and selectivity to the target RNA strand, promising mRNA inhibitory activity and excellent nuclease resistance. Herein, we have obtained a crystal structure that provides insights into these excellent antisense properties. | ||
| + | |||
| + | The crystal structure of a 2',4'-BNA(NC)[N-Me]-modified antisense gapmer in complex with the target RNA.,Kondo J, Nomura Y, Kitahara Y, Obika S, Torigoe H Chem Commun (Camb). 2016 Feb 7;52(11):2354-7. doi: 10.1039/c5cc08300a. PMID:26731288<ref>PMID:26731288</ref> | ||
| + | |||
| + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
| + | </div> | ||
| + | <div class="pdbe-citations 4u6k" style="background-color:#fffaf0;"></div> | ||
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
Revision as of 16:17, 6 July 2022
Crystal structure of DNA/RNA duplex containing 2'-4'-BNA-NC
| |||||||||||
